首页 > 最新文献

BMJ Neurology Open最新文献

英文 中文
Analysis of door-to-needle time for thrombolysis in acute ischaemic stroke using statistical process control charts. 使用统计过程控制图分析急性缺血性脑卒中溶栓治疗从进门到进针的时间。
IF 2.1 Q3 CLINICAL NEUROLOGY Pub Date : 2024-11-12 eCollection Date: 2024-01-01 DOI: 10.1136/bmjno-2024-000687
Markku Grönroos, Ville Hällberg, Mika Helminen, Teemu Koivistoinen, Ari Palomäki

Background: Thrombolysis should be administered as soon as possible to suitable patients with acute ischaemic stroke. We introduced a new protocol for patients who had a stroke to achieve reduced door-to-needle times for the best possible outcome. Since then, we have closely monitored each patient who had a stroke. Our goal was to assess whether statistical process control charts could be useful in detecting deviations in door-to-needle times when using four well-known rules applied by Western Electric (WE rules 1-4).

Methods: We analysed retrospectively door-to-needle times of together 200 acute ischaemic stroke patients before and after the implementation of our new stroke protocol. In addition, 25 patients at the time of reorganisation (transition period) were analysed. Statistical process control chart rules WE 1-WE 4 were applied to detect door-to-needle deviations and to monitor process uniformity.

Results: Before the implementation of the protocol, median door-to-needle time was 53 min and after the implementation 20 min. Statistical process control chart rules were triggered only once in 100 patients before the reorganisation but seven times in 25 patients during the transition period. None of the rules WE 1-4 were activated after the reorganisation, indicating the stability of the reorganised acute ischaemic stroke process.

Conclusions: The use of statistical process control charts demonstrated a significant reduction in door-to-needle times during the reorganisation. Further, it showed that the acute ischaemic stroke process with a 20 min door-to-needle time is very stable.

背景:应尽快对合适的急性缺血性中风患者进行溶栓治疗。我们为中风患者引入了新的治疗方案,以缩短从门诊到进针的时间,从而尽可能获得最佳治疗效果。此后,我们对每位中风患者进行了密切监测。我们的目标是评估统计过程控制图在使用西电公司应用的四种著名规则(WE 规则 1-4)时,是否有助于发现门到针时间的偏差:我们回顾性分析了 200 名急性缺血性脑卒中患者在实施新的脑卒中治疗方案前后的门到针时间。此外,我们还对重组时(过渡期)的 25 名患者进行了分析。统计过程控制图规则WE 1-WE 4用于检测从门到针的偏差并监控过程的一致性:结果:在实施规程前,门到针时间的中位数为 53 分钟,实施规程后为 20 分钟。在重组前,100 名患者中只有 1 次触发了统计流程控制图规则,但在过渡期间,25 名患者中触发了 7 次。重组后,WE 1-4 规则均未被激活,这表明重组后的急性缺血性脑卒中流程具有稳定性:结论:统计流程控制图的使用表明,重组期间门到针时间显著缩短。此外,它还表明门到针时间为 20 分钟的急性缺血性中风流程非常稳定。
{"title":"Analysis of door-to-needle time for thrombolysis in acute ischaemic stroke using statistical process control charts.","authors":"Markku Grönroos, Ville Hällberg, Mika Helminen, Teemu Koivistoinen, Ari Palomäki","doi":"10.1136/bmjno-2024-000687","DOIUrl":"10.1136/bmjno-2024-000687","url":null,"abstract":"<p><strong>Background: </strong>Thrombolysis should be administered as soon as possible to suitable patients with acute ischaemic stroke. We introduced a new protocol for patients who had a stroke to achieve reduced door-to-needle times for the best possible outcome. Since then, we have closely monitored each patient who had a stroke. Our goal was to assess whether statistical process control charts could be useful in detecting deviations in door-to-needle times when using four well-known rules applied by Western Electric (WE rules 1-4).</p><p><strong>Methods: </strong>We analysed retrospectively door-to-needle times of together 200 acute ischaemic stroke patients before and after the implementation of our new stroke protocol. In addition, 25 patients at the time of reorganisation (transition period) were analysed. Statistical process control chart rules WE 1-WE 4 were applied to detect door-to-needle deviations and to monitor process uniformity.</p><p><strong>Results: </strong>Before the implementation of the protocol, median door-to-needle time was 53 min and after the implementation 20 min. Statistical process control chart rules were triggered only once in 100 patients before the reorganisation but seven times in 25 patients during the transition period. None of the rules WE 1-4 were activated after the reorganisation, indicating the stability of the reorganised acute ischaemic stroke process.</p><p><strong>Conclusions: </strong>The use of statistical process control charts demonstrated a significant reduction in door-to-needle times during the reorganisation. Further, it showed that the acute ischaemic stroke process with a 20 min door-to-needle time is very stable.</p>","PeriodicalId":52754,"journal":{"name":"BMJ Neurology Open","volume":"6 2","pages":"e000687"},"PeriodicalIF":2.1,"publicationDate":"2024-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11575376/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142677471","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Statins are rarely prescribed for incidentally discovered covert cerebrovascular disease: a retrospective cohort in a large electronic health record (EHR) identified using natural language processing. 他汀类药物很少用于偶然发现的隐匿性脑血管疾病:利用自然语言处理技术在大型电子健康记录 (EHR) 中发现的回顾性队列。
IF 2.1 Q3 CLINICAL NEUROLOGY Pub Date : 2024-11-11 eCollection Date: 2024-01-01 DOI: 10.1136/bmjno-2024-000855
Lester Y Leung, Eric Puttock, David F Kallmes, Patrick Luetmer, Sunyang Fu, Chengyi X Zheng, Hongfang Liu, Wansu Chen, David M Kent

Introduction: While incidentally discovered covert cerebrovascular diseases (id-CCD) are associated with future stroke, it is not known if patients with id-CCD are prescribed statins.

Methods: Patients age ≥50 with id-CCD on neuroimaging from 2009 to 2019 with no prior ischaemic stroke, transient ischaemic attack or dementia were identified using natural language processing in a large real-world cohort. Robust Poisson multivariable regression was used to assess statin prescription among patients without prior statins.

Results: Among 2 41 050 patients, 74 975 patients (31.1%; 4.7% with covert brain infarcts (CBI); 29.0% with white matter disease (WMD)) had id-CCD. 53.5% (95% CI 53.2 to 53.9%) were not on statins within 6 months prior to the scan. Of those, 12.0% (95% CI 11.7 to 12.3%) were prescribed statins in the next 6 months compared with 9.3% (95% CI 9.1 to 9.4%) in those without CCD, a 2.7% (95% CI 2.4 to 3.1%) absolute increase in statin prescription for those with id-CCD. In adjusted analyses, the presence of id-CCD was only associated with minor increases in statin prescription (CBI or WMD (risk ratio (RR) 1.09, 95% CI 1.05 to 1.13), CBI alone (RR 1.34, 95% CI 1.21 to 1.47), WMD alone (RR 1.05, 95% CI 1.01 to 1.09), and CBI and WMD (RR 1.23, 95% CI 1.12 to 1.35)).

Discussion: Identification of id-CCD is not associated with substantial changes in statin prescription in routine clinical practice.

导言:虽然偶然发现的隐匿性脑血管疾病(id-CCD)与未来中风有关,但id-CCD患者是否被处方他汀类药物尚不清楚:方法:在一个大型真实世界队列中,使用自然语言处理技术识别了2009年至2019年期间神经影像学检查发现id-CCD的≥50岁患者,这些患者既往未患缺血性脑卒中、短暂性脑缺血发作或痴呆症。采用稳健泊松多变量回归评估了既往未服用过他汀类药物的患者的他汀类药物处方情况:在 2 41 050 名患者中,74 975 名患者(31.1%;4.7% 患有隐蔽性脑梗塞 (CBI);29.0% 患有白质疾病 (WMD))患有 id-CCD。53.5%(95% CI 53.2 至 53.9%)的患者在扫描前 6 个月内未服用他汀类药物。其中,12.0%(95% CI 11.7 至 12.3%)的患者在接下来的 6 个月内服用了他汀类药物,而无 CCD 患者的这一比例为 9.3%(95% CI 9.1 至 9.4%),id-CCD 患者服用他汀类药物的绝对比例增加了 2.7%(95% CI 2.4 至 3.1%)。在调整分析中,id-CCD的存在仅与他汀类药物处方的轻微增加有关(CBI或WMD(风险比(RR)1.09,95% CI 1.05至1.13),仅CBI(RR 1.34,95% CI 1.21至1.47),仅WMD(RR 1.05,95% CI 1.01至1.09),以及CBI和WMD(RR 1.23,95% CI 1.12至1.35)):讨论:在常规临床实践中,识别 id-CCD 与他汀类药物处方的重大变化无关。
{"title":"Statins are rarely prescribed for incidentally discovered covert cerebrovascular disease: a retrospective cohort in a large electronic health record (EHR) identified using natural language processing.","authors":"Lester Y Leung, Eric Puttock, David F Kallmes, Patrick Luetmer, Sunyang Fu, Chengyi X Zheng, Hongfang Liu, Wansu Chen, David M Kent","doi":"10.1136/bmjno-2024-000855","DOIUrl":"10.1136/bmjno-2024-000855","url":null,"abstract":"<p><strong>Introduction: </strong>While incidentally discovered covert cerebrovascular diseases (id-CCD) are associated with future stroke, it is not known if patients with id-CCD are prescribed statins.</p><p><strong>Methods: </strong>Patients age ≥50 with id-CCD on neuroimaging from 2009 to 2019 with no prior ischaemic stroke, transient ischaemic attack or dementia were identified using natural language processing in a large real-world cohort. Robust Poisson multivariable regression was used to assess statin prescription among patients without prior statins.</p><p><strong>Results: </strong>Among 2 41 050 patients, 74 975 patients (31.1%; 4.7% with covert brain infarcts (CBI); 29.0% with white matter disease (WMD)) had id-CCD. 53.5% (95% CI 53.2 to 53.9%) were not on statins within 6 months prior to the scan. Of those, 12.0% (95% CI 11.7 to 12.3%) were prescribed statins in the next 6 months compared with 9.3% (95% CI 9.1 to 9.4%) in those without CCD, a 2.7% (95% CI 2.4 to 3.1%) absolute increase in statin prescription for those with id-CCD. In adjusted analyses, the presence of id-CCD was only associated with minor increases in statin prescription (CBI or WMD (risk ratio (RR) 1.09, 95% CI 1.05 to 1.13), CBI alone (RR 1.34, 95% CI 1.21 to 1.47), WMD alone (RR 1.05, 95% CI 1.01 to 1.09), and CBI and WMD (RR 1.23, 95% CI 1.12 to 1.35)).</p><p><strong>Discussion: </strong>Identification of id-CCD is not associated with substantial changes in statin prescription in routine clinical practice.</p>","PeriodicalId":52754,"journal":{"name":"BMJ Neurology Open","volume":"6 2","pages":"e000855"},"PeriodicalIF":2.1,"publicationDate":"2024-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11555097/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142631917","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Wall-eyed bilateral internuclear ophthalmoplegia (WEBINO) syndrome secondary to dorsal pontine infarction. 继发于背侧桥脑梗死的壁眼双侧核内性眼球震颤(WEBINO)综合征。
IF 2.1 Q3 CLINICAL NEUROLOGY Pub Date : 2024-11-11 eCollection Date: 2024-01-01 DOI: 10.1136/bmjno-2024-000746
Lin-Yuan Zhang, Ming Zhu, Yu Wang, Guo-Dong Wang, Yan Wang, Yun-Cheng Wu, Xiao-Ying Zhu

Background: Wall-eyed bilateral internuclear ophthalmoplegia (WEBINO) is an uncommon ocular motor disorder which is featured by binocular exotropia and bilateral internuclear ophthalmoplegia.

Methods: A 71-year-old man with hypertension presented to the emergency department with sudden-onset diplopia. Neurological examination, neuroimaging, blood and cerebrospinal fluid (CSF) testing were performed.

Results: We presented a typical WEBINO syndrome case with a clear dorsal pontine infarction involving bilateral medial longitudinal fasciculi (MLF) on brain MR scan. The patient's eye movement abnormalities improved and MR lesions disappeared at 60-day follow-up after treatment of clopidogrel and atorvastatin. Furthermore, we summarised the aetiology and pathophysiology of WEBINO by retrospectively analysing all published WEBINO cases. We found that WEBINO can result from various underlying pathologies, with inflammation most common in the young, and stroke most common in the elderly. Simultaneous lesions of bilateral MLF definitely contribute to the pathophysiology of WEBINO.

Conclusions: This case underscores the importance of early recognising WEBINO in the emergency department. A timely diagnosis of stroke-induced WEBINO is important so that acute treatment can be considered and for initiating secondary stroke preventive measures to potentially improve the prognosis.

背景:壁眼双侧核内眼肌瘫痪(WEBINO)是一种不常见的眼球运动障碍,主要表现为双眼外斜和双侧核内眼肌瘫痪:一名71岁的高血压患者因突发复视到急诊科就诊。对患者进行了神经系统检查、神经影像学检查、血液和脑脊液(CSF)检测:结果:我们发现了一例典型的 WEBINO 综合征病例,其脑 MR 扫描显示双侧内侧纵筋膜(MLF)有明显的背侧桥脑梗死。在接受氯吡格雷和阿托伐他汀治疗后,患者的眼球运动异常有所改善,MR病变也在60天的随访中消失。此外,我们还通过回顾性分析所有已发表的 WEBINO 病例,总结了 WEBINO 的病因和病理生理学。我们发现,WEBINO 可由各种潜在病因引起,其中炎症最常见于年轻人,而中风最常见于老年人。双侧 MLF 的同时病变无疑是 WEBINO 的病理生理学原因之一:本病例强调了急诊科早期识别 WEBINO 的重要性。结论:本病例强调了急诊科早期识别 WEBINO 的重要性,及时诊断卒中诱发的 WEBINO 非常重要,这样可以考虑进行急性治疗,并启动二级卒中预防措施,从而改善预后。
{"title":"Wall-eyed bilateral internuclear ophthalmoplegia (WEBINO) syndrome secondary to dorsal pontine infarction.","authors":"Lin-Yuan Zhang, Ming Zhu, Yu Wang, Guo-Dong Wang, Yan Wang, Yun-Cheng Wu, Xiao-Ying Zhu","doi":"10.1136/bmjno-2024-000746","DOIUrl":"https://doi.org/10.1136/bmjno-2024-000746","url":null,"abstract":"<p><strong>Background: </strong>Wall-eyed bilateral internuclear ophthalmoplegia (WEBINO) is an uncommon ocular motor disorder which is featured by binocular exotropia and bilateral internuclear ophthalmoplegia.</p><p><strong>Methods: </strong>A 71-year-old man with hypertension presented to the emergency department with sudden-onset diplopia. Neurological examination, neuroimaging, blood and cerebrospinal fluid (CSF) testing were performed.</p><p><strong>Results: </strong>We presented a typical WEBINO syndrome case with a clear dorsal pontine infarction involving bilateral medial longitudinal fasciculi (MLF) on brain MR scan. The patient's eye movement abnormalities improved and MR lesions disappeared at 60-day follow-up after treatment of clopidogrel and atorvastatin. Furthermore, we summarised the aetiology and pathophysiology of WEBINO by retrospectively analysing all published WEBINO cases. We found that WEBINO can result from various underlying pathologies, with inflammation most common in the young, and stroke most common in the elderly. Simultaneous lesions of bilateral MLF definitely contribute to the pathophysiology of WEBINO.</p><p><strong>Conclusions: </strong>This case underscores the importance of early recognising WEBINO in the emergency department. A timely diagnosis of stroke-induced WEBINO is important so that acute treatment can be considered and for initiating secondary stroke preventive measures to potentially improve the prognosis.</p>","PeriodicalId":52754,"journal":{"name":"BMJ Neurology Open","volume":"6 2","pages":"e000746"},"PeriodicalIF":2.1,"publicationDate":"2024-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11555098/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142631919","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessing insomnia after stroke: a diagnostic validation of the Sleep Condition Indicator in self-reported stroke survivors. 评估中风后失眠症:对自我报告的中风幸存者的睡眠状况指标进行诊断验证。
IF 2.1 Q3 CLINICAL NEUROLOGY Pub Date : 2024-10-31 eCollection Date: 2024-01-01 DOI: 10.1136/bmjno-2024-000768
Declan M McLaren, Jonathan Evans, Satu Baylan, Monika Harvey, Megan C Montgomery, Maria Gardani

Background: Insomnia is common after stroke and is associated with poorer recovery and greater risk of subsequent strokes. Yet, no insomnia measures have been validated in English-speaking individuals affected by stroke.

Aims: This prospective diagnostic validation study investigated the discriminatory validity and optimal diagnostic cut-off of the Sleep Condition Indicator when screening for Diagnostic and Statistical Manual of Mental Disorders-fifth edition (DSM-5) insomnia disorder post-stroke.

Methods: A convenience sample of 180 (60.0% women, mean age=49.61 ± 12.41 years) community-based, adult (≥18 years) self-reported stroke survivors completed an online questionnaire. Diagnosis of DSM-5 insomnia disorder was based on analysis of a detailed sleep history questionnaire. Statistical analyses explored discriminant validity, convergent validity, relationships with demographic and mood variables, and internal consistency. Receiver operating characteristic curves were plotted to assess diagnostic accuracy.

Results: Data from the sleep history questionnaire suggested that 75 participants (41.67%) met criteria for DSM-5 insomnia disorder, 33 (18.33%) exhibited symptoms of insomnia but did not meet diagnostic criteria, and 72 (40.0%) had no insomnia symptoms at the time of assessment. The Sleep Condition Indicator (SCI) demonstrated 'excellent' diagnostic accuracy in the detection of insomnia post-stroke, with an area under the curve of 0.86 (95% CI (0.81, 0.91)). The optimal cut-off was determined as being ≤13, yielding a sensitivity of 88.0% and a specificity of 71.43%.

Conclusions: The findings of this study demonstrate the SCI to be a valid and reliable method with which to diagnose DSM-5 insomnia disorder and symptoms post-stroke. However, a lower threshold than is used in the general population may be necessary after stroke.

背景:失眠是中风后的常见病,与较差的恢复情况和较高的后续中风风险有关。目的:本前瞻性诊断验证研究调查了睡眠状况指标在筛查脑卒中后失眠障碍的《精神疾病诊断与统计手册》第五版(DSM-5)时的鉴别有效性和最佳诊断截断值:180 名(60.0% 为女性,平均年龄=49.61 ± 12.41 岁)社区成年(≥18 岁)中风幸存者完成了在线问卷调查。DSM-5失眠症的诊断基于对详细睡眠史问卷的分析。统计分析探讨了判别效度、收敛效度、与人口统计学和情绪变量的关系以及内部一致性。绘制了接收者工作特征曲线,以评估诊断的准确性:睡眠史调查问卷的数据显示,75 名参与者(41.67%)符合 DSM-5 失眠症标准,33 名参与者(18.33%)有失眠症状但不符合诊断标准,72 名参与者(40.0%)在评估时没有失眠症状。睡眠状况指标(SCI)在检测脑卒中后失眠症方面表现出 "极佳 "的诊断准确性,曲线下面积为 0.86(95% CI (0.81, 0.91))。最佳临界值为≤13,灵敏度为88.0%,特异度为71.43%:本研究结果表明,SCI 是诊断 DSM-5 失眠症和卒中后症状的有效而可靠的方法。结论:本研究结果表明,SCI 是诊断脑卒中后 DSM-5 失眠障碍和症状的有效而可靠的方法。
{"title":"Assessing insomnia after stroke: a diagnostic validation of the Sleep Condition Indicator in self-reported stroke survivors.","authors":"Declan M McLaren, Jonathan Evans, Satu Baylan, Monika Harvey, Megan C Montgomery, Maria Gardani","doi":"10.1136/bmjno-2024-000768","DOIUrl":"10.1136/bmjno-2024-000768","url":null,"abstract":"<p><strong>Background: </strong>Insomnia is common after stroke and is associated with poorer recovery and greater risk of subsequent strokes. Yet, no insomnia measures have been validated in English-speaking individuals affected by stroke.</p><p><strong>Aims: </strong>This prospective diagnostic validation study investigated the discriminatory validity and optimal diagnostic cut-off of the Sleep Condition Indicator when screening for Diagnostic and Statistical Manual of Mental Disorders-fifth edition (DSM-5) insomnia disorder post-stroke.</p><p><strong>Methods: </strong>A convenience sample of 180 (60.0% women, mean age=49.61 ± 12.41 years) community-based, adult (≥18 years) self-reported stroke survivors completed an online questionnaire. Diagnosis of DSM-5 insomnia disorder was based on analysis of a detailed sleep history questionnaire. Statistical analyses explored discriminant validity, convergent validity, relationships with demographic and mood variables, and internal consistency. Receiver operating characteristic curves were plotted to assess diagnostic accuracy.</p><p><strong>Results: </strong>Data from the sleep history questionnaire suggested that 75 participants (41.67%) met criteria for DSM-5 insomnia disorder, 33 (18.33%) exhibited symptoms of insomnia but did not meet diagnostic criteria, and 72 (40.0%) had no insomnia symptoms at the time of assessment. The Sleep Condition Indicator (SCI) demonstrated 'excellent' diagnostic accuracy in the detection of insomnia post-stroke, with an area under the curve of 0.86 (95% CI (0.81, 0.91)). The optimal cut-off was determined as being ≤13, yielding a sensitivity of 88.0% and a specificity of 71.43%.</p><p><strong>Conclusions: </strong>The findings of this study demonstrate the SCI to be a valid and reliable method with which to diagnose DSM-5 insomnia disorder and symptoms post-stroke. However, a lower threshold than is used in the general population may be necessary after stroke.</p>","PeriodicalId":52754,"journal":{"name":"BMJ Neurology Open","volume":"6 2","pages":"e000768"},"PeriodicalIF":2.1,"publicationDate":"2024-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11529575/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142570078","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Major vascular events after first incident stroke: a population-based study. 首次中风后的主要血管事件:一项基于人群的研究。
IF 2.1 Q3 CLINICAL NEUROLOGY Pub Date : 2024-10-30 eCollection Date: 2024-01-01 DOI: 10.1136/bmjno-2024-000723
Rayka Malek, Salha Alasiri, Charles D A Wolfe, Abdel Douiri

Background: Recent advances in stroke care have led to improvements in survival and rates of stroke recurrence. However, there is a lack of data on trends of major vascular events, and risk factors associated with non-fatal and fatal outcomes. We aim to identify demographical and clinical factors leading to incidence of subsequent major vascular events after the first-ever stroke.

Methods: 6051 patients' records with first-ever stroke between 1995 and 2018 in South London, UK were analysed. Semicompeting risks models were constructed to estimate factors affecting time to incidence of recurrent stroke, myocardial infarction (MI), mortality and transitions from poststroke recurrence/MI to mortality (indirect mortality). Cumulative incidence functions were plotted for each major vascular event, stratified by stroke subtypes. All models were adjusted for age, sex, socioeconomic status, comorbidities, stroke severity and stroke subtype.

Results: Five years of cumulative incidences were 9.2% (95% CI (8.4% to 10.0%)) for recurrent stroke, 4.4% (95% CI 3.9% to 5.0%) for MI, and 45% (95% CI 44% to 47%) for mortality. Prior atrial fibrillation was associated with 47% increased risk of mortality (HR=1.47 (95% CI 1.23 to 1.75)) and a previous diagnosis of MI was the strongest risk factor for poststroke MI (HR=9.17 (95% CI 6.28 to 13.39)). Stroke unit was associated with a 40% lower hazard of mortality without having a recurrent stroke/MI (HR=0.60 (95% CI 0.50 to 0.72)) and a 39% lower hazard of indirect mortality (HR=0.57 (95% CI 0.37 to 0.87)).

Conclusion: Major vascular events are prevalent after stroke, particularly among those with concurrent vascular conditions. The rate of stroke recurrence plateaued in the last decade, yet MI incidence increased. Targeted strategies to control risk factors are required to reduce the incidence of a second vascular event and prevent progression to mortality in these high-risk groups.

背景:中风治疗的最新进展提高了患者的存活率和中风复发率。然而,关于主要血管事件的趋势以及与非致命性和致命性结果相关的风险因素的数据却很缺乏。我们旨在确定导致首次中风后后续重大血管事件发生率的人口统计学和临床因素。方法:分析了英国南伦敦 1995 年至 2018 年间 6051 名首次中风患者的记录。构建了半竞争风险模型,以估算影响复发中风、心肌梗死(MI)发病率、死亡率和中风后复发/心肌梗死到死亡率(间接死亡率)转变时间的因素。按中风亚型分层,绘制了每种主要血管事件的累积发病率函数。所有模型均根据年龄、性别、社会经济地位、合并症、中风严重程度和中风亚型进行了调整:五年的累积发病率分别为:复发性中风 9.2% (95% CI (8.4% to 10.0%))、心肌梗死 4.4% (95% CI 3.9% to 5.0%)、死亡率 45% (95% CI 44% to 47%)。既往有心房颤动与死亡风险增加 47% 相关(HR=1.47 (95% CI 1.23 to 1.75)),既往诊断为心肌梗死是卒中后心肌梗死的最强风险因素(HR=9.17 (95% CI 6.28 to 13.39))。卒中单元与无复发卒中/心肌梗死的死亡率降低 40% 相关(HR=0.60 (95% CI 0.50 to 0.72)),与间接死亡率降低 39% 相关(HR=0.57 (95% CI 0.37 to 0.87)):结论:中风后主要血管事件很普遍,尤其是在并发血管疾病的患者中。结论:卒中后大血管事件很普遍,尤其是在并发血管疾病的人群中。卒中复发率在过去十年中趋于平稳,但心肌梗死的发生率却有所上升。需要采取有针对性的策略来控制风险因素,以降低二次血管事件的发生率,并防止这些高危人群的死亡率上升。
{"title":"Major vascular events after first incident stroke: a population-based study.","authors":"Rayka Malek, Salha Alasiri, Charles D A Wolfe, Abdel Douiri","doi":"10.1136/bmjno-2024-000723","DOIUrl":"10.1136/bmjno-2024-000723","url":null,"abstract":"<p><strong>Background: </strong>Recent advances in stroke care have led to improvements in survival and rates of stroke recurrence. However, there is a lack of data on trends of major vascular events, and risk factors associated with non-fatal and fatal outcomes. We aim to identify demographical and clinical factors leading to incidence of subsequent major vascular events after the first-ever stroke.</p><p><strong>Methods: </strong>6051 patients' records with first-ever stroke between 1995 and 2018 in South London, UK were analysed. Semicompeting risks models were constructed to estimate factors affecting time to incidence of recurrent stroke, myocardial infarction (MI), mortality and transitions from poststroke recurrence/MI to mortality (indirect mortality). Cumulative incidence functions were plotted for each major vascular event, stratified by stroke subtypes. All models were adjusted for age, sex, socioeconomic status, comorbidities, stroke severity and stroke subtype.</p><p><strong>Results: </strong>Five years of cumulative incidences were 9.2% (95% CI (8.4% to 10.0%)) for recurrent stroke, 4.4% (95% CI 3.9% to 5.0%) for MI, and 45% (95% CI 44% to 47%) for mortality. Prior atrial fibrillation was associated with 47% increased risk of mortality (HR=1.47 (95% CI 1.23 to 1.75)) and a previous diagnosis of MI was the strongest risk factor for poststroke MI (HR=9.17 (95% CI 6.28 to 13.39)). Stroke unit was associated with a 40% lower hazard of mortality without having a recurrent stroke/MI (HR=0.60 (95% CI 0.50 to 0.72)) and a 39% lower hazard of indirect mortality (HR=0.57 (95% CI 0.37 to 0.87)).</p><p><strong>Conclusion: </strong>Major vascular events are prevalent after stroke, particularly among those with concurrent vascular conditions. The rate of stroke recurrence plateaued in the last decade, yet MI incidence increased. Targeted strategies to control risk factors are required to reduce the incidence of a second vascular event and prevent progression to mortality in these high-risk groups.</p>","PeriodicalId":52754,"journal":{"name":"BMJ Neurology Open","volume":"6 2","pages":"e000723"},"PeriodicalIF":2.1,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11529573/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142569996","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development and internal validation of prehospital prediction models for identifying intracerebral haemorrhage in suspected stroke patients. 用于识别疑似中风患者脑出血的院前预测模型的开发和内部验证。
IF 2.1 Q3 CLINICAL NEUROLOGY Pub Date : 2024-10-26 eCollection Date: 2024-01-01 DOI: 10.1136/bmjno-2024-000878
Mohammed Almubayyidh, Adrian R Parry-Jones, David A Jenkins

Introduction: Distinguishing patients with intracerebral haemorrhage (ICH) from other suspected stroke cases in the prehospital setting is crucial for determining the appropriate level of care and minimising the onset-to-treatment time, thereby potentially improving outcomes. Therefore, we developed prehospital prediction models to identify patients with ICH among suspected stroke cases.

Methods: Data were obtained from the Field Administration of Stroke Therapy-Magnesium prehospital stroke trial, where paramedics evaluated multiple variables in suspected stroke cases within the first 2 hours from the last known well time. A total of 19 candidate predictors were included to minimise overfitting and were subsequently refined through the backward exclusion of non-significant predictors. We used logistic regression and eXtreme Gradient Boosting (XGBoost) models to evaluate the performance of the predictors. Model performance was assessed using the area under the receiver operating characteristic curve (AUC), confusion matrix metrics and calibration measures. Additionally, models were internally validated and corrected for optimism through bootstrapping. Furthermore, a nomogram was built to facilitate paramedics in estimating the probability of ICH.

Results: We analysed 1649 suspected stroke cases, of which 373 (23%) were finally diagnosed with ICH. From the 19 candidate predictors, 9 were identified as independently associated with ICH (p<0.05). Male sex, arm weakness, worsening neurological status and high systolic blood pressure were positively associated with ICH. Conversely, a history of hyperlipidaemia, atrial fibrillation, coronary artery disease, ischaemic stroke and improving neurological status were associated with other diagnoses. Both logistic regression and XGBoost demonstrated good calibration and predictive performance, with optimism-corrected sensitivities ranging from 47% to 49%, specificities from 89% to 90% and AUCs from 0.796 to 0.801.

Conclusions: Our models demonstrate good predictive performance in distinguishing patients with ICH from other diagnoses, making them potentially useful tools for prehospital ICH management.

导言:在院前环境中将脑内出血(ICH)患者与其他疑似卒中病例区分开来,对于确定适当的护理级别、最大限度地缩短发病到治疗的时间,从而改善预后至关重要。因此,我们开发了院前预测模型来识别疑似中风病例中的 ICH 患者:方法:数据来自 "卒中治疗现场管理-镁院前卒中试验",在该试验中,医护人员评估了疑似卒中病例从最后一次已知痊愈时间起 2 小时内的多个变量。共纳入了 19 个候选预测因子,以尽量减少过度拟合,随后通过反向排除非显著预测因子对其进行了改进。我们使用逻辑回归和梯度提升(XGBoost)模型来评估预测因子的性能。我们使用接收者工作特征曲线下面积(AUC)、混淆矩阵指标和校准测量来评估模型的性能。此外,还通过自举法对模型进行了内部验证和乐观校正。此外,我们还建立了一个提名图,以方便医护人员估计 ICH 的概率:结果:我们分析了 1649 例疑似中风病例,其中 373 例(23%)最终确诊为 ICH。在 19 个候选预测因子中,有 9 个被确定为与 ICH 独立相关(p结论:我们的模型在区分 ICH 患者和其他诊断方面表现出良好的预测性能,使其成为院前 ICH 管理的潜在有用工具。
{"title":"Development and internal validation of prehospital prediction models for identifying intracerebral haemorrhage in suspected stroke patients.","authors":"Mohammed Almubayyidh, Adrian R Parry-Jones, David A Jenkins","doi":"10.1136/bmjno-2024-000878","DOIUrl":"10.1136/bmjno-2024-000878","url":null,"abstract":"<p><strong>Introduction: </strong>Distinguishing patients with intracerebral haemorrhage (ICH) from other suspected stroke cases in the prehospital setting is crucial for determining the appropriate level of care and minimising the onset-to-treatment time, thereby potentially improving outcomes. Therefore, we developed prehospital prediction models to identify patients with ICH among suspected stroke cases.</p><p><strong>Methods: </strong>Data were obtained from the Field Administration of Stroke Therapy-Magnesium prehospital stroke trial, where paramedics evaluated multiple variables in suspected stroke cases within the first 2 hours from the last known well time. A total of 19 candidate predictors were included to minimise overfitting and were subsequently refined through the backward exclusion of non-significant predictors. We used logistic regression and eXtreme Gradient Boosting (XGBoost) models to evaluate the performance of the predictors. Model performance was assessed using the area under the receiver operating characteristic curve (AUC), confusion matrix metrics and calibration measures. Additionally, models were internally validated and corrected for optimism through bootstrapping. Furthermore, a nomogram was built to facilitate paramedics in estimating the probability of ICH.</p><p><strong>Results: </strong>We analysed 1649 suspected stroke cases, of which 373 (23%) were finally diagnosed with ICH. From the 19 candidate predictors, 9 were identified as independently associated with ICH (p<0.05). Male sex, arm weakness, worsening neurological status and high systolic blood pressure were positively associated with ICH. Conversely, a history of hyperlipidaemia, atrial fibrillation, coronary artery disease, ischaemic stroke and improving neurological status were associated with other diagnoses. Both logistic regression and XGBoost demonstrated good calibration and predictive performance, with optimism-corrected sensitivities ranging from 47% to 49%, specificities from 89% to 90% and AUCs from 0.796 to 0.801.</p><p><strong>Conclusions: </strong>Our models demonstrate good predictive performance in distinguishing patients with ICH from other diagnoses, making them potentially useful tools for prehospital ICH management.</p>","PeriodicalId":52754,"journal":{"name":"BMJ Neurology Open","volume":"6 2","pages":"e000878"},"PeriodicalIF":2.1,"publicationDate":"2024-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11529750/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142570086","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Minimising the rate of vascular complications in Deep Brain Stimulation surgery for the management of Parkinson's disease: a single-centre 600-patient case series. 将脑深部刺激手术治疗帕金森病的血管并发症发生率降至最低:单中心 600 例患者系列研究。
IF 2.1 Q3 CLINICAL NEUROLOGY Pub Date : 2024-10-26 eCollection Date: 2024-01-01 DOI: 10.1136/bmjno-2024-000793
Raymond Cook, Nyssa Chennell Dutton, Peter A Silburn, Linton J Meagher, George Fracchia, Nathan Anderson, Glen Cooper, Hoang-Mai Dinh, Stuart J Cook, Paul Silberstein

Objectives: Deep Brain Stimulation (DBS) is an effective, yet underused therapy for people living with Parkinson's disease (PD) in whom tremor, motor fluctuations and/or dyskinesia are not satisfactorily controlled by oral medical therapy. Fear of vascular complications related to the operative procedure remains a strong reason for both the referrer and patient reluctance. We review the incidence of vascular complications in the first 600 patients with Parkinson's disease treated at our centre by a single neurologist/neurosurgical team.

Methods: Surgical data routinely collected for patients who underwent DBS implantation for the management of PD between the years 2001-2023 was retrospectively reviewed. Incidences of vascular complication were analysed in detail, examining causal factors.

Results: Including reimplantations, 600 consecutive DBS patients underwent implantation with 1222 DBS electrodes. Three patients (0.50%) experienced vascular complications.

Conclusion: This vascular complication rate is at the low end of that reported in the literature. Risk mitigation strategies discussed include a consistent neurosurgical team, dual methodology target and trajectory planning, control of cerebrospinal fluid egress during the procedure, use of a specialised microelectrode recording (MER)/macrostimulation electrode without an introducing brain cannula and low number of MER passes. A reduced vascular complication rate may improve the acceptability of DBS therapy for both patients and referrers.

目标:对于震颤、运动波动和/或运动障碍无法通过口服药物得到满意控制的帕金森病(Parkinson's disease,PD)患者来说,脑深部刺激术(Deep Brain Stimulation,DBS)是一种有效但未得到充分利用的疗法。担心与手术过程相关的血管并发症仍然是转诊者和患者不愿接受治疗的一个重要原因。我们回顾了本中心由一名神经学家/神经外科团队治疗的前 600 名帕金森病患者的血管并发症发生率:我们对 2001-2023 年间常规收集的接受 DBS 植入治疗帕金森病患者的手术数据进行了回顾性分析。对血管并发症的发生率进行了详细分析,并研究了致病因素:包括再植入手术在内,600 名连续接受 DBS 治疗的患者共植入了 1222 个 DBS 电极。3名患者(0.50%)出现血管并发症:这一血管并发症发生率在文献报道中处于较低水平。所讨论的降低风险策略包括:神经外科团队保持一致、双方法目标和轨迹规划、手术过程中控制脑脊液流出、使用专用微电极记录(MER)/宏观刺激电极而不引入脑插管以及减少 MER 穿刺次数。血管并发症发生率的降低可提高患者和转诊者对 DBS 治疗的接受度。
{"title":"Minimising the rate of vascular complications in Deep Brain Stimulation surgery for the management of Parkinson's disease: a single-centre 600-patient case series.","authors":"Raymond Cook, Nyssa Chennell Dutton, Peter A Silburn, Linton J Meagher, George Fracchia, Nathan Anderson, Glen Cooper, Hoang-Mai Dinh, Stuart J Cook, Paul Silberstein","doi":"10.1136/bmjno-2024-000793","DOIUrl":"10.1136/bmjno-2024-000793","url":null,"abstract":"<p><strong>Objectives: </strong>Deep Brain Stimulation (DBS) is an effective, yet underused therapy for people living with Parkinson's disease (PD) in whom tremor, motor fluctuations and/or dyskinesia are not satisfactorily controlled by oral medical therapy. Fear of vascular complications related to the operative procedure remains a strong reason for both the referrer and patient reluctance. We review the incidence of vascular complications in the first 600 patients with Parkinson's disease treated at our centre by a single neurologist/neurosurgical team.</p><p><strong>Methods: </strong>Surgical data routinely collected for patients who underwent DBS implantation for the management of PD between the years 2001-2023 was retrospectively reviewed. Incidences of vascular complication were analysed in detail, examining causal factors.</p><p><strong>Results: </strong>Including reimplantations, 600 consecutive DBS patients underwent implantation with 1222 DBS electrodes. Three patients (0.50%) experienced vascular complications.</p><p><strong>Conclusion: </strong>This vascular complication rate is at the low end of that reported in the literature. Risk mitigation strategies discussed include a consistent neurosurgical team, dual methodology target and trajectory planning, control of cerebrospinal fluid egress during the procedure, use of a specialised microelectrode recording (MER)/macrostimulation electrode without an introducing brain cannula and low number of MER passes. A reduced vascular complication rate may improve the acceptability of DBS therapy for both patients and referrers.</p>","PeriodicalId":52754,"journal":{"name":"BMJ Neurology Open","volume":"6 2","pages":"e000793"},"PeriodicalIF":2.1,"publicationDate":"2024-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11529736/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142570002","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Review of theories into the pathogenesis of normal pressure hydrocephalus. 正常压力脑积水发病机制理论回顾。
IF 2.1 Q3 CLINICAL NEUROLOGY Pub Date : 2024-10-17 eCollection Date: 2024-01-01 DOI: 10.1136/bmjno-2024-000804
Racheed Mani, Jade Basem, Liu Yang, Susan Fiore, Petar Djuric, Michael Egnor

Normal pressure hydrocephalus (NPH) represents a unique form of hydrocephalus characterised by the paradox of ventriculomegaly without significant elevations in intracranial pressure, with the clinical triad of gait instability, cognitive impairment, and urinary incontinence. A myriad of neurobiological correlates have been implicated in its pathophysiology. We review the literature to provide an up-to-date, narrative review of the proposed mechanisms underlying the pathophysiology of NPH, proposing a holistic framework through which to understand the condition. We conducted a narrative review of the literature on NPH, assessing the various mechanisms underlying its pathophysiology and clinical presentation. NPH represents a unique form of hydrocephalus manifesting as a disorder of the cerebral vasculature, characterised by arteriosclerosis and reduced intracranial elastance. There are multiple mechanisms underlying its pathophysiology, which include windkessel impairment causing redistribution of intracranial pulsatility from the subarachnoid space to the ventricles, reductions in cerebral blood flow, impaired glymphatic clearance, reduced blood-brain barrier integrity and alterations in venous haemodynamics. Moreover, NPH shares similar clinical features and pathological mechanisms as other neurodegenerative conditions such as Alzheimer's disease and vascular dementia. The severity of each respective mechanism of pathophysiology can lead a patient to develop one condition versus another. Analysing NPH as a disorder of the cerebral vasculature, glymphatics, and most of all, the distribution of intracranial pulsatility, provides a novel framework through which to understand and manage this condition, one which requires further investigation.

正常压力脑积水(NPH)是一种独特的脑积水形式,其特点是脑室肿大而颅内压无明显升高的矛盾现象,并伴有步态不稳、认知障碍和尿失禁的临床三联征。该病的病理生理学与多种神经生物学相关。我们回顾了相关文献,对 NPH 的病理生理学基础机制进行了最新的叙述性回顾,并提出了一个整体框架来理解该病症。我们对有关 NPH 的文献进行了叙述性综述,评估了其病理生理学和临床表现的各种机制。NPH 是一种独特的脑积水,表现为脑血管功能紊乱,以动脉硬化和颅内弹性降低为特征。其病理生理学基础有多种机制,包括风口受损导致颅内搏动性从蛛网膜下腔向脑室的重新分布、脑血流量减少、甘油清除受损、血脑屏障完整性降低和静脉血液动力学改变。此外,NPH 与阿尔茨海默病和血管性痴呆等其他神经退行性疾病有着相似的临床特征和病理机制。每种病理生理学机制的严重程度都会导致患者出现不同的病症。将 NPH 分析为脑血管、甘油三酯以及最重要的颅内搏动分布的紊乱,为理解和管理这种疾病提供了一个新的框架,需要进一步研究。
{"title":"Review of theories into the pathogenesis of normal pressure hydrocephalus.","authors":"Racheed Mani, Jade Basem, Liu Yang, Susan Fiore, Petar Djuric, Michael Egnor","doi":"10.1136/bmjno-2024-000804","DOIUrl":"10.1136/bmjno-2024-000804","url":null,"abstract":"<p><p>Normal pressure hydrocephalus (NPH) represents a unique form of hydrocephalus characterised by the paradox of ventriculomegaly without significant elevations in intracranial pressure, with the clinical triad of gait instability, cognitive impairment, and urinary incontinence. A myriad of neurobiological correlates have been implicated in its pathophysiology. We review the literature to provide an up-to-date, narrative review of the proposed mechanisms underlying the pathophysiology of NPH, proposing a holistic framework through which to understand the condition. We conducted a narrative review of the literature on NPH, assessing the various mechanisms underlying its pathophysiology and clinical presentation. NPH represents a unique form of hydrocephalus manifesting as a disorder of the cerebral vasculature, characterised by arteriosclerosis and reduced intracranial elastance. There are multiple mechanisms underlying its pathophysiology, which include windkessel impairment causing redistribution of intracranial pulsatility from the subarachnoid space to the ventricles, reductions in cerebral blood flow, impaired glymphatic clearance, reduced blood-brain barrier integrity and alterations in venous haemodynamics. Moreover, NPH shares similar clinical features and pathological mechanisms as other neurodegenerative conditions such as Alzheimer's disease and vascular dementia. The severity of each respective mechanism of pathophysiology can lead a patient to develop one condition versus another. Analysing NPH as a disorder of the cerebral vasculature, glymphatics, and most of all, the distribution of intracranial pulsatility, provides a novel framework through which to understand and manage this condition, one which requires further investigation.</p>","PeriodicalId":52754,"journal":{"name":"BMJ Neurology Open","volume":"6 2","pages":"e000804"},"PeriodicalIF":2.1,"publicationDate":"2024-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11487818/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142480534","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence and characteristics of headache among medical students in Egypt: a multicentric cross-sectional study. 埃及医学生头痛的患病率和特征:一项多中心横断面研究。
IF 2.1 Q3 CLINICAL NEUROLOGY Pub Date : 2024-10-15 eCollection Date: 2024-01-01 DOI: 10.1136/bmjno-2024-000851
Rashad G Mohamed, Khalid Sarhan, Basma Kamel, Rahma M Almetwaly, Eslam E Fouda, Mostafa Meshref, Sara Bioumy, Doaa Alemam, Hebatalla A Ahmed

Background: Headaches are one of the most common neurological disorders, ranging in severity from mild discomfort to a severe, debilitating condition. Headaches are particularly prevalent among medical students, which can be attributed to various factors such as psychological stressors, extensive studying, long hours of clinical rotations and high-pressure examination. This study aims to ascertain the prevalence of different types of headaches, along with analysing their associated clinical characteristics among medical students in Egypt.

Methods: A multicentric, descriptive questionnaire-based cross-sectional study was conducted across five governmental faculties of medicine in Egypt from November 2022 to March 2023. Using a multistage random sampling method, 600 undergraduate students were selected to participate. Headache was diagnosed based on the International Classification of Headache Disorders.

Results: A total of 493 responses were included in the analysis; the prevalence of headache disorder was 264 (53.5%), with tension-type headaches (TTH) frequent episodic being the highest 89 (33.7%), while TTH chronic and migraine with aura were the least prevalent, accounting for 10 (3.8%) and 31 (11.7%), respectively. Women exhibited a higher overall headache prevalence (69.4%) compared with men (44.4%). A positive family history was found in 120 (45.5%) of students with headache. Lack of sleep and stress were the most frequently reported potential triggers for headaches. Out of 264 medical students, 171 (65%) took analgesics. Only 42 (24.6%) had a medical consultation, while most students 129 (75.4%) took over-the-counter medications.

Conclusion: Notably, headaches were prevalent in 264 (53.5%) of the respondents. TTH frequent and infrequent emerged as the most common headaches among medical students, followed by migraine without aura then migraine with aura. Participants were statistically different according to sex, faculty, academic year and living conditions. Alarmingly, despite the substantial prevalence, only 42 (24.6%) students sought medical consultation.

背景:头痛是最常见的神经系统疾病之一,严重程度从轻微不适到严重衰弱不等。头痛在医科学生中尤为普遍,这可归因于各种因素,如心理压力、大量学习、长时间临床轮转和高压考试。本研究旨在确定不同类型头痛的发病率,并分析其在埃及医学生中的相关临床特征:方法:2022 年 11 月至 2023 年 3 月,在埃及五所政府医学院开展了一项多中心、描述性问卷调查横断面研究。研究采用多阶段随机抽样法,共选取了 600 名本科生参与研究。头痛的诊断依据是《国际头痛疾病分类》:共有 493 份答复被纳入分析;头痛疾病的患病率为 264(53.5%),其中紧张型头痛(TTH)频繁发作的患病率最高,为 89(33.7%),而 TTH 慢性头痛和有先兆偏头痛的患病率最低,分别为 10(3.8%)和 31(11.7%)。与男性(44.4%)相比,女性的头痛总发病率更高(69.4%)。120名(45.5%)头痛学生有阳性家族史。睡眠不足和压力是最常见的头痛潜在诱因。在 264 名医学生中,有 171 人(65%)服用止痛药。只有 42 名学生(24.6%)接受过医疗咨询,而大多数学生有 129 名(75.4%)服用非处方药:值得注意的是,264 名受访者(53.5%)普遍存在头痛问题。医学生最常见的头痛是经常性和非经常性 TTH,其次是无先兆偏头痛和有先兆偏头痛。根据性别、院系、学年和生活条件的不同,受访者的情况也存在统计学差异。令人担忧的是,尽管发病率很高,但只有42名(24.6%)学生求医。
{"title":"Prevalence and characteristics of headache among medical students in Egypt: a multicentric cross-sectional study.","authors":"Rashad G Mohamed, Khalid Sarhan, Basma Kamel, Rahma M Almetwaly, Eslam E Fouda, Mostafa Meshref, Sara Bioumy, Doaa Alemam, Hebatalla A Ahmed","doi":"10.1136/bmjno-2024-000851","DOIUrl":"https://doi.org/10.1136/bmjno-2024-000851","url":null,"abstract":"<p><strong>Background: </strong>Headaches are one of the most common neurological disorders, ranging in severity from mild discomfort to a severe, debilitating condition. Headaches are particularly prevalent among medical students, which can be attributed to various factors such as psychological stressors, extensive studying, long hours of clinical rotations and high-pressure examination. This study aims to ascertain the prevalence of different types of headaches, along with analysing their associated clinical characteristics among medical students in Egypt.</p><p><strong>Methods: </strong>A multicentric, descriptive questionnaire-based cross-sectional study was conducted across five governmental faculties of medicine in Egypt from November 2022 to March 2023. Using a multistage random sampling method, 600 undergraduate students were selected to participate. Headache was diagnosed based on the International Classification of Headache Disorders.</p><p><strong>Results: </strong>A total of 493 responses were included in the analysis; the prevalence of headache disorder was 264 (53.5%), with tension-type headaches (TTH) frequent episodic being the highest 89 (33.7%), while TTH chronic and migraine with aura were the least prevalent, accounting for 10 (3.8%) and 31 (11.7%), respectively. Women exhibited a higher overall headache prevalence (69.4%) compared with men (44.4%). A positive family history was found in 120 (45.5%) of students with headache. Lack of sleep and stress were the most frequently reported potential triggers for headaches. Out of 264 medical students, 171 (65%) took analgesics. Only 42 (24.6%) had a medical consultation, while most students 129 (75.4%) took over-the-counter medications.</p><p><strong>Conclusion: </strong>Notably, headaches were prevalent in 264 (53.5%) of the respondents. TTH frequent and infrequent emerged as the most common headaches among medical students, followed by migraine without aura then migraine with aura. Participants were statistically different according to sex, faculty, academic year and living conditions. Alarmingly, despite the substantial prevalence, only 42 (24.6%) students sought medical consultation.</p>","PeriodicalId":52754,"journal":{"name":"BMJ Neurology Open","volume":"6 2","pages":"e000851"},"PeriodicalIF":2.1,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11481110/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142480533","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Paroxysmal sympathetic hyperactivity caused by neurosyphilis. 神经梅毒引起的阵发性交感神经功能亢进。
IF 2.1 Q3 CLINICAL NEUROLOGY Pub Date : 2024-10-15 eCollection Date: 2024-01-01 DOI: 10.1136/bmjno-2024-000814
Shuko Fujiki, Masaki Fujino, Akira Machida

Background: Paroxysmal sympathetic hyperactivity (PSH) is a condition characterised by dysregulation of the autonomic nervous system commonly associated with severe traumatic brain injury. Recently, non-traumatic causes, such as infections and autoimmune conditions, have also been reported as potential triggers.

Case presentation: A 30-year-old man presented with convulsions following 5 days of soliloquy, insomnia and agitation. Neurosyphilis was diagnosed based on elevated non-treponemal and treponemal test findings in the serum and cerebrospinal fluid. Intravenous penicillin administration improved his alertness; however, by day 9, he experienced recurrent episodes of tachycardia, tachypnoea, hyperthermia, hypertension, limb stiffness and diaphoresis. The exclusion of sepsis, pulmonary embolism and malignant syndrome, combined with unremarkable interictal electroencephalogram findings and a high PSH Assessment Measure Score, led to a PSH diagnosis on day 40. Treatment with propranolol, gabapentin and clonidine resolved the episodes, and the patient regained independent ambulation.

Conclusions: This is the first reported case of neurosyphilis accompanied by PSH. Although PSH is rare in central nervous system infections compared with traumatic brain injury, early recognition is crucial, as untreated cases can persist and result in severe complications.

背景:阵发性交感神经功能亢进(PSH)是一种以自主神经系统失调为特征的疾病,通常与严重的脑外伤有关。最近,非创伤性原因,如感染和自身免疫性疾病,也被报道为潜在的诱发因素:一名 30 岁男子在独语、失眠和躁动 5 天后出现抽搐。根据血清和脑脊液中升高的非抗梅毒试验和抗梅毒试验结果,诊断为神经梅毒。静脉注射青霉素改善了他的警觉性;然而,到了第 9 天,他反复出现心动过速、呼吸急促、高热、高血压、肢体僵硬和全身乏力。由于排除了败血症、肺栓塞和恶性综合征的可能性,加上发作间期脑电图结果无异常,以及 PSH 评估测量得分较高,因此在第 40 天确诊为 PSH。普萘洛尔、加巴喷丁和氯硝柳胺的治疗缓解了发作,患者恢复了独立行走能力:这是首例神经梅毒合并 PSH 的病例。尽管与脑外伤相比,PSH在中枢神经系统感染中较为罕见,但早期识别至关重要,因为未经治疗的病例可能持续存在并导致严重并发症。
{"title":"Paroxysmal sympathetic hyperactivity caused by neurosyphilis.","authors":"Shuko Fujiki, Masaki Fujino, Akira Machida","doi":"10.1136/bmjno-2024-000814","DOIUrl":"https://doi.org/10.1136/bmjno-2024-000814","url":null,"abstract":"<p><strong>Background: </strong>Paroxysmal sympathetic hyperactivity (PSH) is a condition characterised by dysregulation of the autonomic nervous system commonly associated with severe traumatic brain injury. Recently, non-traumatic causes, such as infections and autoimmune conditions, have also been reported as potential triggers.</p><p><strong>Case presentation: </strong>A 30-year-old man presented with convulsions following 5 days of soliloquy, insomnia and agitation. Neurosyphilis was diagnosed based on elevated non-treponemal and treponemal test findings in the serum and cerebrospinal fluid. Intravenous penicillin administration improved his alertness; however, by day 9, he experienced recurrent episodes of tachycardia, tachypnoea, hyperthermia, hypertension, limb stiffness and diaphoresis. The exclusion of sepsis, pulmonary embolism and malignant syndrome, combined with unremarkable interictal electroencephalogram findings and a high PSH Assessment Measure Score, led to a PSH diagnosis on day 40. Treatment with propranolol, gabapentin and clonidine resolved the episodes, and the patient regained independent ambulation.</p><p><strong>Conclusions: </strong>This is the first reported case of neurosyphilis accompanied by PSH. Although PSH is rare in central nervous system infections compared with traumatic brain injury, early recognition is crucial, as untreated cases can persist and result in severe complications.</p>","PeriodicalId":52754,"journal":{"name":"BMJ Neurology Open","volume":"6 2","pages":"e000814"},"PeriodicalIF":2.1,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11481103/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142480531","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
BMJ Neurology Open
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1